Tobacco

The Neuroscience of Fear: Why Pre-Movie 'Mukesh' Ads Don't Actually Cure Addiction

Dr. Sidharth Sood May 28, 2026 9 min read
The Neuroscience of Fear: Why Pre-Movie 'Mukesh' Ads Don't Actually Cure Addiction

The Neuroscience of Fear: Why Pre-Movie “Mukesh” Ads Don’t Actually Cure Addiction

Every Indian moviegoer knows them: the pre-movie “Mukesh” ads with graphic images of diseased lungs, throat cancer, oral cancer, and premature death.

They’re shocking. They’re designed to terrify. And they’re almost completely ineffective at stopping smoking.

In fact, they might make the problem worse.

The Fear-Based Approach Doesn’t Work (Neuroscience Explains Why)

India’s anti-smoking advertising relies heavily on fear: graphic imagery, death statistics, diseased organs.

The logic is straightforward: Show people how awful smoking is, and they’ll quit.

The neuroscience says otherwise.

What Happens in the Addicted Brain During Fear Ads

When an active smoker watches a fear-based anti-smoking ad:

  1. Amygdala activates - Fear and threat detection center fires up
  2. Negative emotions spike - Anxiety, distress, shame
  3. Dopamine urges intensify - The brain seeks relief from negative emotions
  4. Craving increases - Nicotine suddenly feels more rewarding as an escape
  5. Result: Smoking rates don’t decrease; relapse risk increases

This is called the “boomerang effect”—fear-based messaging actually increases drug cravings by creating emotional distress that the drug used to (and can) relieve.

The Clinical Evidence Against Fear-Based Campaigns

Multiple meta-analyses show:

  • Fear-based anti-smoking ads have minimal sustained impact on quit rates
  • Fear increases smokers’ defensiveness and denial
  • Smokers in distress seek the drug more intensely, not less
  • The most vulnerable smokers (those with depression, anxiety) are most harmed by fear messaging
  • Short-term shock wears off within hours or days; craving persists

One study followed 1,000 smokers watching fear-based ads: quit rates improved for exactly 12 hours on average.

Meanwhile, addiction doesn’t take a day off.

Why Fear Fails: The Addiction Paradox

Here’s the fundamental problem: Nicotine is a fear-relief drug.

When smokers experience:

  • Stress
  • Anxiety
  • Emotional pain
  • Shame
  • Distress

They reach for cigarettes because nicotine:

  • Reduces anxiety (dopamine system)
  • Provides immediate relief
  • Creates temporary emotional calm

A fear-based ad showing “Mukesh” creates exactly the emotional state that drives smokers toward cigarettes.

Fear-based advertising isn’t just ineffective. It’s counterproductive.

What Actually Works: Evidence-Based Approaches

Research on effective cessation messaging shows:

1. Intrinsic Motivation, Not Fear

People quit successfully when motivated by:

  • Better health (not fear of disease)
  • Financial savings
  • Improved relationships
  • Personal goals and identity
  • Internal reasons, not external terror

The messaging that works: “You can do this” not “You’ll die if you don’t”

2. Specific Behavioral Support

Effective campaigns provide:

  • Access to treatment resources
  • Practical quit strategies
  • Information on medications
  • Professional support contact details
  • Realistic timelines

Not just fear.

3. Addressing Root Needs

Most successful programs address why people smoke:

  • Stress management (instead of fear-mongering)
  • Anxiety treatment
  • Social support
  • Coping skills training
  • Often psychiatric care for comorbid conditions

4. Combination Approach

The most effective anti-smoking strategies include:

  • Medical treatment - Varenicline, bupropion, NRT
  • Behavioral therapy - CBT, motivational interviewing
  • Professional support - Psychiatrists, counselors, support groups
  • Environmental changes - Smoke-free spaces, social support
  • Positive messaging - About capability and freedom, not fear

The “Mukesh” Problem: Fear Without Solutions

India’s famous “Mukesh” anti-smoking ads show graphic disease imagery—then offer no treatment pathway.

From a neuroscience perspective, this is harmful:

Creates fear without relief - Activates stress response ✗ No behavioral alternative - Smoker is distressed but unsupported ✗ Increases shame - Smoker feels judged, not helped ✗ Drives toward cigarettes - Fear becomes another reason to smoke (especially problematic for smokers with co-occurring depression) ✗ No medication mentioned - Smoker doesn’t know effective treatments exist

What Should Work: Evidence-Based Anti-Smoking Campaigns

Effective public health messaging should:

Provide hope - “Quitting is possible with proper support” ✓ Offer specific resources - Phone numbers, websites, medications, doctors ✓ Address psychological needs - Stress, anxiety, emotional coping ✓ Explain treatment options - Varenicline, bupropion, NRT, therapy ✓ Build internal motivation - Why quitting serves your goals ✓ Normalize professional help - Frame psychiatry as smart, not shameful

The Bottom Line: Fear Doesn’t Heal Addiction

Fear-based anti-smoking campaigns are:

  • Neurobiologically counterproductive
  • Ineffective at changing behavior long-term
  • Potentially harmful to vulnerable smokers
  • A waste of public health resources

What actually works:

  • Evidence-based medical treatment
  • Professional psychiatric care
  • Behavioral support
  • Positive messaging + practical resources
  • Addressing underlying mental health

Your Path to Quitting

If you’re ready to quit, skip the fear and go straight to evidence-based treatment:

  1. See a psychiatrist - Proper assessment and medication selection
  2. Combine medication + therapy - Varenicline/NRT + behavioral support
  3. Address underlying conditions - Treat depression, anxiety, stress
  4. Build internal motivation - Your reasons to quit, not someone else’s fear

Learn about smoking cessation treatment | Evidence-based tobacco addiction resources


Ready to quit smoking with proper support?

Book 20-Minute Consultation | WhatsApp Support

This article discusses neuroscience and public health messaging. It should not replace professional psychiatric evaluation.

Dr. Sidharth Sood

Psychiatrist & Addiction Specialist
MBBS | MD Psychiatry | DM Addiction Psychiatry (AIIMS)

Dr. Sidharth Sood is a Neuropsychiatrist and Addiction Psychiatry Specialist based in New Delhi. With training from AIIMS and expertise in neuromodulation therapies, he provides evidence-based psychiatric care for depression, anxiety, addiction, and other mental health conditions. Committed to compassionate, personalized care and patient education.

Book Consultation

Need Professional Help?

If you're struggling with any of the issues discussed in this article, Dr. Sidharth Sood is here to help.